Advanced search
Publication Cover
Epigenomics Volume 15, 2023 - Issue 10
Submit an article Journal homepage
101
Views
0
CrossRef citations to date
0
Altmetric
Editorial

Role of Epigenetic Modifications in Parkinson’s Disease

Jian-Nan Zhang1 Department of Neurobiology, School of Basic Medical Sciences, Capital Medical University, Beijing, 100069, ChinaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-5200-7368
ORCID Icon,
Qian Li2 Beijing Key Laboratory of Neural Regeneration & Repair, Capital Medical University, Beijing, 100069, China;3 Department of Biochemistry & Molecular Biology, School of Basic Medical Sciences, Capital Medical University, Beijing, 100069, China;4 Beijing Key Laboratory of Cancer Invasion & Metastasis Research, Capital Medical University, Beijing, 100069, ChinaORCID Iconhttps://orcid.org/0000-0003-0359-5604
ORCID Icon &
Fei Yang1 Department of Neurobiology, School of Basic Medical Sciences, Capital Medical University, Beijing, 100069, China;2 Beijing Key Laboratory of Neural Regeneration & Repair, Capital Medical University, Beijing, 100069, China
Pages 573-576 | Received 13 Jun 2023, Accepted 27 Jun 2023, Published online: 11 Jul 2023

References

  • Bloem BR , OkunMS , KleinC. Parkinson’s disease. Lancet397(10291), 2284–2303 (2021).
  • Masliah E , DumaopW , GalaskoD , DesplatsP. Distinctive patterns of DNA methylation associated with Parkinson’s disease: identification of concordant epigenetic changes in brain and peripheral blood leukocytes. Epigenetics8(10), 1030–1038 (2013).
  • Jowaed A , SchmittI , KautO , WüllnerU. Methylation regulates alpha-synuclein Expression and is decreased in Parkinson’s disease patients’ brains. J. Neurosci.30(18), 6355–6359 (2010).
  • Guhathakurta S , EvangelistaBA , GhoshS , BasuS , KimY-S. Hypomethylation of intron1 of α-synuclein gene does not correlate with Parkinson’s disease. Mol. Brain10(1), 6 (2017).
  • Rubino A , D’AddarioC , DiBartolomeo Met al. DNA methylation of the 5′-UTR DAT 1 gene in Parkinson’s disease patients. Acta Neurol. Scand.142(3), 275–280 (2020).
  • Wang Y , WangX , LiRet al. A DNA methyltransferase inhibitor, 5-aza-2′-deoxycytidine, exacerbates neurotoxicity and upregulates Parkinson’s disease-related genes in dopaminergic neurons. CNS Neurosci. Ther.19(3), 183–190 (2013).
  • Wu T-T , LiuT , LiXet al. TET2-mediated Cdkn2A DNA hydroxymethylation in midbrain dopaminergic neuron injury of Parkinson’s disease. Hum. Mol. Genet.29(8), 1239–1252 (2020).
  • Guhathakurta S , SongMK , BasuS , JeG , CristovaoAC , KimY-S. Regulation of alpha-synuclein gene (SNCA) by epigenetic modifier TET1 in Parkinson disease. Int. Neurourol. J.26(Suppl. 2), S85–S93 (2022).
  • Schmitt I , KautO , KhaznehHet al. L-dopa increases α-synuclein DNA methylation in Parkinson’s disease patients in vivo and in vitro: L-Dopa and SNCA DNA methylation. Mov. Disord.30(13), 1794–1801 (2015).
  • Toker L . Genome-wide histone acetylation analysis reveals altered transcriptional regulation in the Parkinson’s disease brain. Mol. Neurodegener.16(1), 31 (2021).
  • Kontopoulos E , ParvinJD , FeanyMB. Alpha-synuclein acts in the nucleus to inhibit histone acetylation and promote neurotoxicity. Hum. Mol. Genet.15(20), 3012–3023 (2006).
  • Park G , TanJ , GarciaG , KangY , SalvesenG , ZhangZ. Regulation of histone acetylation by autophagy in Parkinson’s disease. J. Biol. Chem.291(7), 3531–3540 (2016).
  • Wang L , LiuL , HanCet al. Histone deacetylase 4 inhibition reduces rotenone-induced alpha-synuclein accumulation via autophagy in SH-SY5Y cells. Brain Sci.13(4), 670 (2023).
  • Lemos M , StefanovaN. Histone deacetylase 6 and the disease mechanisms of α-synucleinopathies. Front. Synaptic Neurosci.12, 586453 (2020).
  • Li Y , GuZ , LinSet al. Histone deacetylases as epigenetic targets for treating Parkinson’s disease. Brain Sci.12(5), 672 (2022).
  • Kraus TFJ , HaiderM , SpannerJ , SteinmaurerM , DietingerV , KretzschmarHA. Altered long noncoding RNA expression precedes the course of Parkinson’s disease-a preliminary report. Mol. Neurobiol.54(4), 2869–2877 (2017).
  • Cressatti M , JuwaraL , GalindezJMet al. Salivary microR-153 and microR-223 levels as potential diagnostic biomarkers of idiopathic Parkinson’s disease. Mov. Disord.35(3), 468–477 (2020).
  • Li X , SiW , LiZet al. miR-335 promotes ferroptosis by targeting ferritin heavy chain 1 in in vivo and in vitro models of Parkinson’s disease. Int. J. Mol. Med.47(4), 61 (2021).
  • Liu Y , LuZ. Long non-coding RNA NEAT1 mediates the toxic of Parkinson’s disease induced by MPTP/MPP+ via regulation of gene expression. Clin. Exp. Pharmacol. Physiol.45(8), 841–848 (2018).
  • Wang W , LvR , ZhangJ , LiuY. circSAMD4A participates in the apoptosis and autophagy of dopaminergic neurons via the miR-29c-3p-mediated AMPK/mTOR pathway in Parkinson’s disease. Mol. Med. Rep.24(1), 540 (2021).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.